Robert Andrade Fennec Pharmaceuticals Inc. (FENC) insider trading activity

Robert Andrade is CHIEF FINANCIAL OFFICER of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 110,523 shares of FENC, which is worth approximately $479,669. The most recent transaction as insider was on Sep 30, 2024, when has been sold 1,042 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 111K

1.92% 3M change

11.38% 12M change

Total Value Held $479,669

Robert Andrade Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2024	BUY Grant, award, or other acquisition	-	1,042 Added 0.93%	110,523 Common Shares
Aug 31 2024	BUY Grant, award, or other acquisition	-	1,042 Added 0.94%	109,481 Common Shares
Jul 31 2024	BUY Grant, award, or other acquisition	-	1,042 Added 0.95%	108,439 Common Shares
Jul 01 2024	BUY Grant, award, or other acquisition	-	1,042 Added 0.96%	107,397 Common Shares
May 31 2024	BUY Grant, award, or other acquisition	-	1,042 Added 0.97%	106,355 Common Shares
Apr 30 2024	BUY Grant, award, or other acquisition	-	1,042 Added 0.98%	105,313 Common Shares
Apr 01 2024	BUY Open market or private purchase	-	12,500 Added 10.7%	104,271 Common Shares
Mar 26 2024	SELL Open market or private sale	$152,327 $10.9 p/Share	13,975 Reduced 13.22%	91,771 Common Shares
Mar 25 2024	SELL Open market or private sale	$153,725 $11.0 p/Share	13,975 Reduced 11.67%	105,746 Common Shares
Jan 05 2024	SELL Open market or private sale	$156,150 $10.41 p/Share	15,000 Reduced 11.13%	119,721 Common Shares
Jan 04 2024	SELL Open market or private sale	$159,600 $10.64 p/Share	15,000 Reduced 10.02%	134,721 Common Shares
Jun 30 2023	SELL Open market or private sale	$66,150 $8.82 p/Share	7,500 Reduced 5.67%	124,721 Common Shares
Jun 30 2023	BUY Exercise of conversion of derivative security	$61,250 $2.45 p/Share	25,000 Added 14.31%	149,721 Common Shares
Jun 29 2023	SELL Open market or private sale	$67,275 $8.97 p/Share	7,500 Reduced 5.37%	132,221 Common Shares
Jun 28 2023	SELL Open market or private sale	$89,900 $8.99 p/Share	10,000 Reduced 6.68%	139,721 Common Shares
Dec 30 2022	SELL Open market or private sale	$52,855 $9.61 p/Share	5,500 Reduced 3.54%	149,721 Common Shares
Dec 29 2022	SELL Open market or private sale	$52,635 $9.57 p/Share	5,500 Reduced 3.42%	155,221 Common Shares
Dec 28 2022	SELL Open market or private sale	$105,710 $9.61 p/Share	11,000 Reduced 6.41%	160,721 Common Shares
Sep 21 2022	SELL Sale (or disposition) back to the issuer	$162,704 $8.54 p/Share	19,052 Reduced 9.99%	171,721 Common Shares
Sep 21 2022	BUY Grant, award, or other acquisition	-	37,500 Added 16.43%	190,773 Common Shares

Robert Andrade

CHIEF FINANCIAL OFFICER

Research Triangle Park, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FENC shares.

Notify only if

Value

Insider Trading

Get notified when an Fennec Pharmaceuticals Inc. insider buys or sells FENC shares.

Notify only if

Operation

Value

Type

News

Receive news related to FENNEC PHARMACEUTICALS INC.

Track Activities on FENC

Account